UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure

Not Applicable

Completed

Conditions: Blood Pressure

Interventions: Other: Unattended blood pressure measurement
Other: Ambulatory blood pressure monitoring
Other: Attended blood pressure measurement
Other: Home blood pressure monitoring

First Posted Date: 2020-03-13

Last Posted Date: 2024-12-13

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 654

Registration Number: NCT04307004

Locations: 🇺🇸
Columbia University Medical Center - Hypertension Center, New York, New York, United States
🇺🇸
University of Alabama at Birmingham Hypertension Research Clinic, Birmingham, Alabama, United States

Increasing Naloxone Access for Persons Who Use Opioids

Phase 4

Completed

Conditions: Naloxone

Interventions: Drug: Opioid Overdose Education with Naloxone Distribution
Drug: Opioid Overdose Education

First Posted Date: 2020-03-10

Last Posted Date: 2023-10-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 111

Registration Number: NCT04303000

Locations: 🇺🇸
Craigslist, Montgomery, Alabama, United States

The Impact of Insomnia on Pain in HIV

Recruiting

Conditions: HIV
Insomnia

Interventions: Diagnostic Test: Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)sleep disorders-revised
Diagnostic Test: Resmed ApneaLink Air device (Resmed, San Diego, CA).
Other: Quantitative Sensory testing (QST)
Diagnostic Test: OraQuick Advance Rapid HIV 1/2 Swab test
Diagnostic Test: Cluster of Differentiation 4 (CD4) and Viral load

First Posted Date: 2020-03-06

Last Posted Date: 2024-07-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 240

Registration Number: NCT04298658

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Abemaciclib 150 MG by mouth twice daily
Drug: Androgen deprivation therapy (ADT)
Radiation: Radiation Therapy

First Posted Date: 2020-03-06

Last Posted Date: 2025-03-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 9

Registration Number: NCT04298983

Locations: 🇺🇸
University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States

Reducing Chronic Disease Health Disparities in the Deep South

Not Applicable

Completed

Conditions: Chronic Disease

Interventions: Behavioral: Harvest for Health

First Posted Date: 2020-03-06

Last Posted Date: 2022-12-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 137

Registration Number: NCT04297826

Locations: 🇺🇸
Various Counties (Bullock, Calhoun, Dallas, Madison, Marengo, Monroe, Sumter, Talladega, Walker), Birmingham, Alabama, United States
🇺🇸
Various Counties (Bolivar, Grenada, Humphreys, Panola, Sunflower, Yazoo), Jackson, Mississippi, United States

A Health and Wellness Lifestyle Program to Support Community-Dwelling Persons With Traumatic Brain Injury

Not Applicable

Completed

Conditions: Traumatic Brain Injury

Interventions: Behavioral: Telehealth-Based Health and Wellness Program (POWERS-TBI)

First Posted Date: 2020-02-28

Last Posted Date: 2023-10-31

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 62

Registration Number: NCT04288258

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2

Active, not recruiting

Conditions: Neurofibromatosis 2
Progressive Vestibular Schwannoma (VS)

Interventions: Drug: Crizotinib

First Posted Date: 2020-02-25

Last Posted Date: 2023-09-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 19

Registration Number: NCT04283669

Locations: 🇺🇸
Children's National Medical Center (Site 775), Washington DC, District of Columbia, United States
🇺🇸
Children's HealthCare of Atlanta (Site 950), Atlanta, Georgia, United States
🇺🇸
Lurie Childrens Hospital of Chicago (Site 350), Chicago, Illinois, United States

and more 12 locations

Decreased Neuraxial Morphine After Cesarean Delivery

Early Phase 1

Completed

Conditions: Anesthesia

Interventions: Drug: Morphine Sulfate 150 mcg
Drug: Morphine Sulfate 50mcg

First Posted Date: 2020-02-20

Last Posted Date: 2025-03-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 87

Registration Number: NCT04279054

Locations: 🇺🇸
UAB Women and Infants Center, Birmingham, Alabama, United States

Effects of Alcohol and Mood on Attention

Not Applicable

Terminated

Conditions: Suicidal Ideas

Interventions: Other: Alcohol administration
Other: Placebo administration
Behavioral: Positive mood induction
Behavioral: Negative mood induction

First Posted Date: 2020-02-19

Last Posted Date: 2025-03-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 26

Registration Number: NCT04276779

Locations: 🇺🇸
Caitlin Clevenger, Birmingham, Alabama, United States

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients with Advanced PET/MR Imaging

Phase 1

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Drug: [18F]-FDG

First Posted Date: 2020-02-18

Last Posted Date: 2024-12-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 20

Registration Number: NCT04273555

Locations: 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy